Nap time is over. Get ready to rumble!!They are playing possum on the news. Who will jump first?OCTOBER is not to long to wait for PDUFA. Rhucin SPA trial will wind up around that time. 2012 will be very good, even from $4.80 - $5.10.One other thing - KABOOM!!!!
I guess SNTS made a statement today!AFFY, I need more, maybe low $10's is it on the pullback?
Just stuck a big toe in the pond.
Wow, was that you making a splash in TSRX? It popped nicely!
Thanks Kitty. Good suggestion. The executive group looks very solid and a number have led other companies in acquisitions by big pharma. Product also looks very promising. Any other insights on the company would be welcome.
Will Snts go back to $5.10?
Volume is dried up. ????????????????????????I hope so, at some point. I will continue holding my shares.
Who wants a cheap ticket to go to the SNTS dance? The ticket price is cheap now ($4.85) for a stock worth considerably higher. SNTS is a Tiny company with HUGE potential: Offering a number of growing products on the market, keeping earnings positive, while we wait on the relative mammoth pipeline developments. Uceris, Rhucin, and Rifamycin.This company was reformed much stronger after Zegrid setback with a diverse product marketing campaign and bolstered pipeline.Kitty sees SEVEN conservatively, TEN in reach. Hold on until a year or two from now and see how big you can smile. GL from SK
I sometimes get them confused. I have IBS and am looking at rifaximin. Is rifamycin similar?